Lantern Pharma Inc.
NASDAQ:LTRN
Lantern Pharma Inc.
NASDAQ:LTRN
Price:
1.62
USD
Market Closed
Market Cap:
$18.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Lantern Pharma Inc.
NASDAQ:LTRN
|
US |
|
City Pub Group PLC
LSE:CPC
|
UK |
|
S
|
Shenzhen Pagoda Industrial Group Corp Ltd
HKEX:2411
|
CN |
|
B
|
Banqup Group SA
XBRU:BANQ
|
BE |
|
Avro India Ltd
NSE:AVROIND
|
IN |
|
Hotel Sahid Jaya International Tbk PT
IDX:SHID
|
ID |
|
Anabatic Technologies Tbk PT
IDX:ATIC
|
ID |
|
Vitesco Technologies Group AG
XETRA:VTSC
|
DE |
|
T
|
Tibet Duo Rui Pharmaceutical Co Ltd
SZSE:301075
|
CN |
|
Shree Digvijay Cement Co Ltd
NSE:SHREDIGCEM
|
IN |
|
Prakash Industries Ltd
NSE:PRAKASH
|
IN |
|
GeneDx Holdings Corp
NASDAQ:WGS
|
US |
|
ASE Technology Holding Co Ltd
NYSE:ASX
|
TW |
|
P
|
PVI Holdings
VN:PVI
|
VN |
|
Murchison Minerals Ltd
XTSX:MUR
|
CA |
|
Northwest Pipe Co
NASDAQ:NWPX
|
US |
|
Kyokuto Boeki Kaisha Ltd
TSE:8093
|
JP |
|
Universal Corp
NYSE:UVV
|
US |
|
C
|
China Huirong Financial Holdings Ltd
HKEX:1290
|
CN |
|
Herc Holdings Inc
NYSE:HRI
|
US |
|
Sunwood Corp
TSE:8903
|
JP |
|
D
|
Dswiss Inc
OTC:DQWS
|
MY |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of LTRN.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
LTRN
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
LTRN Competitors Multiples
Lantern Pharma Inc. Competitors
Lantern Pharma Inc. Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Lantern Pharma Inc.
NASDAQ:LTRN
|
17.9m USD | 0 | -0.9 | -0.3 | -0.3 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
365.4B USD | 6 | 87.3 | 14.5 | 20.1 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
184.6B USD | 5 | 23.9 | 13.9 | 13.9 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173.9B USD | 5.9 | 20.5 | 12.8 | 15.8 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.3B USD | 9.2 | 27.9 | 20.9 | 21.9 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.7B USD | 5.6 | 17.9 | 13.4 | 15.2 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67B AUD | 3 | 33.2 | 11.2 | 14 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.6B EUR | 11.3 | 36.2 | 39.3 | 40.1 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
